Resource Development for Insomnia Treatment

Resource Development for Insomnia Treatment

Do you practice CBT for Insomnia? 

Would you like to be involved in a community effort to create a needed resource?

In the field of behavioral sleep medicine (BSM), the sleep diary is an essential and ubiquitous tool. While there has been progress in creating a standard sleep diary form, there has not yet been any advances in providing practitioners with a common and easy to use interface for this standard.

This has left providers stuck with the task of calculating sleep data in inefficient  ways such as by pen and paper or ‘re-inventing the wheel’ by creating their own  means of calculating and tracking the data via MS excel or MS access. Large  amounts of time and creativity are lost as people’s efforts to tackle this problem are not shared with the community.

To address this problem Dr. Scott Rower is leading a team of people in the BSM community to create a simple and accessible user interface based on the standardized consensus sleep diary.  This freely available webpage will allow any provider the ability to calculate their patient’s sleep data in order to inform treatment decision making.

Want to get involved?  Learn more here.

This project is funded through an internal grant at Portland Psychotherapy Clinic, Research & Training Center

5 Excellent Reasons to Treat Insomnia

5 Excellent Reasons to Treat Insomnia

1. Insomnia can cause depression.

A collection of research suggests that untreated insomnia doubles the chance of developing depression, as a causal factor (4 sources – one, two, three, four)

2. Insomnia often does not resolve once the depression is treated or without focused insomnia treatment (source 1; source 2)

3. Untreated insomnia more than doubles the chance of relapse of depression and other mental health diagnoses.  (source 1; source 2)

4. Effective, short-term, focused insomnia treatment exists

Cognitive Therapy for Insomnia (CBT-I) produces significant, sustained relief that is comparable to medications in the short-term & more effective in the long-term (4 meta-analyses – onetwo, three, four).

5. Insomnia represents a significant factor in non-response to treatment (source).

Conclusion

Insomnia is a major factor in clinical response and vulnerability to mental illness.  It does not tend to improve without focused treatment.  Treatment exists & over 30 years of evidence suggests that CBT-I is the most effective. 

UPCOMING TRAINING EVENTS


Using Acceptance and Commitment Therapy to Guide Exposure Therapy: The Basics

Brian Thompson, PhD, Brian Pilecki, PhD, and Joanne Chan, PsyD
September 17th, 2021 from 12-3pm

This is a beginner workshop intended to provide the foundations of exposure therapy including types of exposure interventions and design effective exposure exercises for various anxiety disorders and OCRDs. Participants will learn how to use ACT processes to guide the implementation of exposure techniques and how ACT processes may be enhanced by traditional exposure methods. This workshop will provide some background in theory and will emphasize applying exposure to clinical contexts using case studies, exposure demonstrations, and the practice of new skills by participants. Read More.


Overcoming Barriers to Effective ACT-Informed Exposure Therapy

Brian Thompson, PhD and Brian Pilecki, PhD
October 15th, 2021 from 12-3pm

This workshop will offer a brief introduction to Acceptance and Commitment Therapy-informed exposure and focus on practical ways to address common problems in implementation. Case examples will be provided to illustrate common client barriers such as lack of buy-in and difficulty grasping core ACT concepts. Strategies for overcoming these barriers will be offered and participants will have the opportunity to practice newly acquired skills through role-plays and break-out rooms.Read More.


Therapy and Research in Psychedelic Science (TRIPS) Seminar Series

Second Friday of each month from 12:00 PM – 1:00 PM (PT)

TRIPS is an online seminar series that hosts speakers discussing science-informed presentations and discussions about psychedelics to educate healthcare professionals. This series was created to guide healthcare providers and students preparing to be professionals towards the most relevant, pragmatic, and essential information about psychedelic-assisted therapy, changing legal statuses, and harm reduction approaches in order to better serve clients and communities. This seminar series is a fundraiser for our clinical trial of MDMA-assisted psychotherapy for social anxiety disorder that Portland Psychotherapy investigators are preparing for and starting in the Fall of 2021. All proceeds after presenter remuneration will go to fund this clinical trial. Read more.

September 10th, 2021 – Cultural Considerations in Outreach to and Assessment of Minoritized/Marginalized Individuals in Psychedelic-Assisted Psychotherapy with Terence Ching, Ph.D.

October 8th, 2021Presentation Title TBA – Dr. Elizabeth Nielson

November 12th, 2021Presentation Title TBA – Anthony Bossis, Ph.D.

December 10th, 2021Presentation Title TBA – Jamilah R. George

January 14th, 2022Presentation Title TBA – Jordan Sloshower, MD, MSc